SCHEMBL31350832

SCHEMBL31350832

N#CNc1ncc(Br)cc1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.37
EGFR P00533 5/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ERBB2 P04626 3/20 0.34
DYRK1A Q13627 2/20 0.33
AURKA O14965 1/20 0.33
DAPK3 O43293 1/20 0.33
JAK2 O60674 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33
PAK4 O96013 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
FYN P06241 1/20 0.33
RET P07949 1/20 0.33
MET P08581 1/20 0.33
PDGFRB P09619 1/20 0.33
PIM1 P11309 1/20 0.33
FGFR1 P11362 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17591608 0.81 EGFR (0.37) CHEK1EGFRCYP11B1CYP11B2ERBB2
SCHEMBL19328130 0.79 PGK1 (0.44) CHEK1EGFRERBB2ALDH1A1MAPT
SCHEMBL4099333 0.78 DYRK1A (0.41) EGFRERBB2DYRK1ALRRK2DYRK1B
SCHEMBL31350683 0.78 OPRK1 (0.36) EGFRCYP11B1CYP11B2ERBB2KDR
SCHEMBL31350596 0.78 OPRK1 (0.36) EGFRCYP11B1CYP11B2ERBB2KDR
SCHEMBL19327981 0.77 PDE10A (0.45) CHEK1EGFRERBB2LRRK2ALDH1A1
SCHEMBL19328050 0.76 USP2 (0.40) PRKCQLRRK2CLK4ALDH1A1CYP1A2
SCHEMBL19328092 0.75 SMN1; SMN2 (0.47) EGFRERBB2CDK8ALDH1A1MAPT
SCHEMBL29477047 0.75 CCNA2 (0.48) EGFRAURKAALDH1A1MAPTCYP1A2
SCHEMBL27241771 0.75 EGFR (0.41) EGFRERBB2KDRALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 EP disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 WO disclosed